Category: Pharmaceuticals
Adios Aduhelm
The controversial and never-proven-effective drug to treat Alzheimer's disease, aducanumab (Aduhelm) has been discontinued.
First CRISPR Treatment Approval
The first CRISPR-based therapy approval is a milestone worthy of noting.
Decongestant doesn’t work, concludes FDA advisory committee
An FDA advisory committee has concluded that phenylephrine, a popular decongestant in cough and cold remedies, is ineffective.
The (Cold) Drugs Don’t Work
The FDA continues to permit the inclusion of an ineffective ingredient in hundreds of cough and cold products.
How the “Don’t take this medication with grapefruit juice” warning originated
How a chance discovery by one scientist improved the safety of consumers worldwide.
The Polypill Comes of Age
The polypill is effective for secondary prevention of cardiovascular disease. By combining drugs in a single pill, it improves convenience and compliance.
PreP for HIV/AIDS
Two pills and an injection are FDA-approved to prevent HIV infection. Not enough patients and providers know about them.
Zinc for the prevention or treatment of respiratory tract infections: A new systematic review
A new systematic review examines the evidence for zinc to prevent or treat respiratory tract infections.
What are the risks of touching fentanyl?
There is the widespread belief that simply touching fentanyl can be fatal. This assumption isn't supported by science or evidence.
Melatonin poisonings in children are increasing
Melatonin use is increasing, and accelerated during the pandemic. Overdoses are also increasing in children, and in rare cases are linked to serious harms.